| First Author | Kralova J | Year | 2020 |
| Journal | J Immunol | Volume | 204 |
| Issue | 6 | Pages | 1607-1620 |
| PubMed ID | 32024700 | Mgi Jnum | J:287607 |
| Mgi Id | MGI:6406050 | Doi | 10.4049/jimmunol.1900953 |
| Citation | Kralova J, et al. (2020) Dysregulated NADPH Oxidase Promotes Bone Damage in Murine Model of Autoinflammatory Osteomyelitis. J Immunol 204(6):1607-1620 |
| abstractText | Autoinflammatory diseases are characterized by dysregulation of the innate immune system, leading to spontaneous inflammation. Pstpip2(cmo) mouse strain is a well-characterized model of this class of disorders. Because of the mutation leading to the lack of adaptor protein PSTPIP2, these animals suffer from autoinflammatory chronic multifocal osteomyelitis similar to several human syndromes. Current evidence suggests that it is driven by hyperproduction of IL-1beta by neutrophil granulocytes. In this study, we show that in addition to IL-1beta, PSTPIP2 also negatively regulates pathways governing reactive oxygen species generation by neutrophil NOX2 NADPH oxidase. Pstpip2(cmo) neutrophils display highly elevated superoxide production in response to a range of stimuli. Inactivation of NOX2 NADPH oxidase in Pstpip2(cmo) mice did not affect IL-1beta levels, and the autoinflammatory process was initiated with similar kinetics. However, the bone destruction was almost completely alleviated, suggesting that dysregulated NADPH oxidase activity is a key factor promoting autoinflammatory bone damage in Pstpip2(cmo) mice. |
